Context: Adolescents with differentiated thyroid cancer (DTC) require lifelong monitoring with a high possibility of reoperation or radioactive iodine. Although adult DTC survivors have similar or slightly worse quality of life (QOL), this has not been evaluated in the pediatric population.
C
hildhood-onset differentiated thyroid cancer (DTC) is a rare disease, although the incidence is increasing by 1.1% per year (1, 2) . DTC in children is distinct from the adult disease in that it is generally more aggressive at diagnosis with cervical lymph node involvement in 40-90% and distant metastases in 20-30% of children (1, 3) . Ultimately, even in the presence of more aggressive disease, the prognosis is excellent (1, 2) .
Given these factors, adolescents diagnosed with DTC face a lifetime of ongoing monitoring for recurrence or metastases with a high possibility for reoperation or multiple courses of radioactive iodine. From our clinical experience, adolescents with DTC experience significant stress related to the diagnosis and follow-up, which may lead to lower perceived quality of life (QOL) and increased anxiety. Adult thyroid cancer survivors have worse or similar QOL compared with healthy controls (4 -6) . To our knowledge, this has not been evaluated in the pediatric population.
The aim of this pilot study was to compare QOL and anxiety levels in adolescent DTC patients with patients with acquired autoimmune hypothyroidism. As a secondary objective, QOL and anxiety scores in DTC patients were compared with known standards from the general healthy population. Our hypothesis was that pediatric DTC patients have lower QOL and higher anxiety levels compared with patients with autoimmune hypothyroidism and the healthy pediatric population.
Subjects and Methods

Subjects and controls
This was a single-center, cross-sectional, case-control study of patients followed for DTC at The Hospital for Sick Children (Toronto, Canada) and were recruited over a 6-month period during regular clinic visits. Participants were aged 10 -18 yr, diagnosed with DTC, and not actively experiencing L-T 4 withdrawal or recombinant TSH treatment. The control group consisted of children with autoimmune hypothyroidism receiving L-T 4 therapy. This group was chosen for comparison because they are generally healthy, but must take L-T 4 daily and receive life-long care with clinic visits every 6 months. Participants were excluded if 1) they had other comorbidities, 2) they were not proficient in the English language, and 3) they had documented active psychosis, suicidality, or substance dependence. The study was approved by the Research Ethics Board, and parental informed consent and child assent were obtained before participating in the study.
Instruments for assessment of QOL and anxiety
1) The PedsQL version 4.0 Generic Core Scales Inventory (PedsQL 4.0) is a standardized tool that assesses patient and parent perceptions of QOL. The measurement scales include physical, emotional, social, and school functioning scored on a five-point Likert scale. Scores range from 0 -100 with higher scores reflecting better QOL. This tool distinguishes between children with and without a chronic condition and distinguishes disease severity within children with chronic conditions (7, 8) .
2) The Multidimensional Anxiety Scale for Children (MASC) is a scale used in children to assess anxiety levels. The measurement scales includes physical symptoms, social anxiety, harm avoidance, and separation anxiety scored on a four-point Likert scale. The scores are converted into standard T-scores, and a T-score higher than 65 indicates the presence of anxiety symptoms (9, 10).
3) The Coddington Life Events Scales (CLES) is a self-report scale used in children to assess the influence of life events that require an adaptive response by an individual (11, 12) . Each item describes a life event and quantifies the number occurred during the previous year. Measurement of significant life events is in terms of life change units (LCU). LCU scores above the 75th percentile are considered higher risk for physical and emotional problems. This scale was included to screen for external issues that may impact QOL or anxiety.
The QOL and anxiety scores in DTC patients were also compared with known standards obtained from the general healthy population for the PedsQL 4.0 (13) and MASC (9) scales.
Statistical analysis
Descriptive statistics were used to characterize demographic variables. Student's unpaired t test and Mann Whitney U test were used to compare QOL and anxiety between groups. Pearson correlations were performed for association between QOL and anxiety scores to age, TSH, free T 4 (FT 4 ), and time since diagnosis and for correlation of QOL scores between patients and parent proxy. The study was powered to detect a difference of 13 points in PedsQL 4.0 total score and 6.8 points in the MASC total score between the DTC and the autoimmune hypothyroidism patients. A sample size of 16 for each group was powered at an ␣-level of 0.05 and ␤ of 0.8 to detect this difference assuming a SD of 12.7 based on previous studies for PedsQL 4.0 (13) and SD of 6.6 based on previous studies for MASC (9) . Bonferroni correction was performed for multiple comparisons, and P Ͻ 0.001 was considered significant. Statistical analysis was performed using SAS version 8.2 software (SAS, Cary, NC).
Results
During the study period, 19 eligible DTC patients were approached, and three patients declined participation. There was no difference in age and time since diagnosis between those who declined and those who participated. Twenty-two patients with autoimmune hypothyroidism were approached; three declined participation, and three patients did not return questionnaires.
Sixteen children (nine females) with DTC were compared with 16 children (eight females) in the control group. Age of the DTC group was significantly higher than the control group (15.0 Ϯ 1.9 vs. 12.3 Ϯ 2.7 yr, respectively; P ϭ 0.005). Time since diagnosis in the DTC group was as follows: less than 12 months, 25%; 12-24 months, 12.5%; and more than 24 months, 62.5%. Time since diagnosis in the control group was as follows: less than 12 months, 19%; 12-24 months, 25%; and more than 24 months, 56%. TSH levels were significantly lower in the DTC group compared with the control group [median (range) ϭ 0.66 (0.01-23.3) vs. 3.66 (0.46 -22.3) mU/liter, respectively; P ϭ 0.013]. FT 4 levels were significantly higher in the DTC group compared with the control group (24.5 Ϯ 7.6 vs. 17.5 Ϯ 4.3 pmol/liter, respectively; P ϭ 0.001). The median autoantibody titer for the control group was 455 IU/ml (range 51-1657).
In the DTC group, 13 (81%) had papillary carcinoma, two (12.5%) had follicular variant of papillary carcinoma, and one (6%) had follicular carcinoma. Five children (31%) had lymph node involvement, and two children (12.5%) had lung metastases at diagnosis. At the time of assessment, 11 patients were in remission and five had persistent disease. Ten children had one surgery, and six children had two surgeries. Ten children had one episode of radioactive iodine, five children had two episodes, and one child had three episodes. The mean number of episodes of L-T 4 withdrawal or recombinant TSH treatment was 3.63 Ϯ 1.78.
QOL, anxiety level, and life events (Table 1)
The total scores for the child and parent-proxy QOL and anxiety level didn't differ between DTC patients compared with controls and with known standards obtained from the general healthy population of youth. The scales and subscales scores for the children QOL, parent-proxy QOL, and anxiety level did not differ between DTC patients and the control group. Compared with known standards obtained from the general healthy population, DTC patients had significantly lower score for emotional functioning in the parent-proxy QOL report (72.19 Ϯ 22.36 vs. 81.31 Ϯ 16.50, respectively; P ϭ 0.03). LCU scores did not differ between DTC patients compared with controls.
Association between QOL and anxiety levels and clinical and biochemical variables in the DTC group
No correlation was found between children QOL scores and age, time since diagnosis, TSH, and FT 4 levels at assessment. TSH levels were positively correlated to social anxiety subscale score (r ϭ 0.54, P ϭ 0.04). The total scores for the children QOL and anxiety level did not differ between DTC patients in remission compared with those with persistent disease.
Correlation between patients and parent-proxy QOL scores
Sixteen parents in the DTC group and 15 parents in the control group completed the parent-proxy QOL survey. There was a significant positive correlation between patients and parent-proxy QOL for the DTC group and acquired autoimmune hypothyroidism controls for total scores (r ϭ 0.65, P ϭ 0.006; and r ϭ 0.62, P ϭ 0.014, respectively) and for the subscales scores (data not shown).
Discussion
The aim of this pilot study was to compare QOL and anxiety levels in adolescent DTC patients with patients with acquired autoimmune hypothyroidism. We found that adolescents with DTC have similar QOL and anx- iety levels compared with patients with autoimmune hypothyroidism and with a healthy normative population. To our knowledge, this is the first study in the pediatric age range in patients with DTC to evaluate QOL and anxiety. Adult thyroid cancer survivors have been reported to have worse or similar QOL compared with healthy controls (4 -6). In adults, greater time from diagnosis but not TSH at assessment was reported to be correlated with higher QOL (4, 6) . The use of recombinant TSH vs. L-T 4 withdrawal has also been associated with better QOL (5, 14) . Anxiety has been found to rise acutely with L-T 4 withdrawal but has also been shown to be higher in those on suppressive L-T 4 therapy (15, 16) . In this study, there was no correlation found between children's QOL scores and age, time since diagnosis, and TSH and FT 4 levels at assessment. We could not assess the effect of recombinant TSH vs. L-T 4 withdrawal due to the small sample size.
It is well known in the pediatric cancer literature that children with other forms of cancer, including acute lymphoblastic leukemia and brain tumors, have significantly lower QOL than healthy controls. Compared with long-term survivors, newly diagnosed patients during treatment overall reported lower QOL (13) . In a recent systematic review, long-term pediatric cancer survivors have shown overall QOL to be similar compared with population norms (17) . Compared with siblings, long-term pediatric cancer survivors have shown significantly lower scores only in the physical well-being domain (18) . Characteristics such as high adaptability and tendency to exaggerate the positive aspect of life and understate the negative may account for higher QOL scores in long-term pediatric cancer survivors (17) . These explanations may well be applied to adolescents with DTC. Other explanations may relate to the discussion of excellent prognosis and follow-up in endocrinology clinics rather than oncology clinics with other cancer patients.
A limitation of this study includes a small sample size that reflects the rarity of the condition. In addition, the cross-sectional design does not allow us to detect changes in QOL over time. Possible selection bias, age differences between the groups, and the lack of socioeconomic data are also limitations of the study. Lastly, measures used to assess QOL and anxiety do not include pediatric thyroidspecific items.
In conclusion, this pilot study is the first study to examine QOL and anxiety levels in adolescents with DTC. Finding that levels are within the normal range for the general population and a control group with autoimmune hypothyroidism is promising. Additional studies, prospective in nature, with a larger number of patients and including qualitative exploration of their cancer experience are warranted to confirm these findings and to determine what supportive interventions may be needed for these patients in the clinical setting.
